Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF, FRA:T2X) delivered a strong first quarter, with revenue up to $74.3 million and net income rising to $46.7 million as a gold price of $4,820 per ounce more than offset lower sales volumes. The company is on track for 75,000 to 85,000 ounces of production this year and is advancing toward a final investment decision at its Douta project in Senegal. Read more
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) is guiding for at least 15% revenue growth this year after a strong first half, with revenue up 23% and its order book growing 38% to £18.1 million. A £10 million fundraise will accelerate the company's TechBio strategy, including a partnership with Medidata, whose platform is used in 80% of FDA novel drug approvals. Watch more
EMV Capital (AIM:EMVC, FRA:NTK1) grew assets under management 14% to £112.5 million in 2025, with group losses falling 83% to £0.6 million as revenue rose 17%. CEO Dr Ilian Iliev says the group is increasingly optimistic as portfolio companies approach key commercial and regulatory milestones. Watch more
Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) has signed a definitive agreement to sell its 75% stake in a non-core gold asset near Kalgoorlie for A$750,000, freeing up capital and management focus for the Pitfield Titanium Project. Pitfield has a mineral resource of 2.2 billion tonnes grading 5.1% TiO₂, making it one of the largest titanium discoveries globally. Read more
Coiled Therapeutics (AIM:COIL, OTCQB:COTXF) has begun trading on the US OTCQB market under the ticker COTXF, giving American investors dollar-denominated access to the oncology company's shares. CEO Sridhar Vempati says 2026 will be "a transformational year," with recent clinical data from its ongoing trial showing an 80% clinical benefit rate. Read more
Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.